U.S. Marine and Shipping Stock News

AAR’s new commercial distribution role with Woodward AAR (AIR) has signed a multi year commercial distribution agreement with Woodward, making AAR the preferred distributor of high demand consumable engine parts for airlines using CFM LEAP, GEnx, and CF34 engines. See our latest analysis for AAR. AAR’s share price return has been strong, with a year to date gain of 32.5% and a 1 year total shareholder return of 90.37%. This suggests momentum has been building around the stock as the Woodward...

CleanSpark (NasdaqCM:CLSK) is accelerating a shift from pure Bitcoin mining toward hosting AI and high performance computing data centers. The company is in advanced talks with a potential investment grade hyperscaler tenant for direct data center capacity. New greenfield AI data center construction is underway in Georgia, backed by CleanSpark’s existing power portfolio. Management is publicly addressing concerns around data center power and water usage as part of this transition. For you...

Amgen (NasdaqGS:AMGN) has been selected by the FDA as one of only two companies to run proof of concept trials under the new real time clinical trials initiative. The program is designed to enable continuous clinical development with real time data sharing between companies and the FDA. The collaboration focuses on reshaping how trials are designed, monitored, and adapted during the development of new therapies. Amgen is a large biotechnology company with a broad portfolio of therapies and...

In early May 2026, Entergy Corporation filed a follow-on equity offering of US$2.18 billion in common stock, shortly after reporting first-quarter 2026 revenue of US$3,187.63 million and net income of US$384.92 million. An interesting aspect is that Entergy is seeking to raise a very large amount of new equity just days after posting higher year-on-year sales and net income, which may influence how investors view its capital needs and future projects. We’ll now examine how this sizable...

Investors may be wondering if Prudential Financial at around US$100 a share still offers value, or if most of the opportunity has already been priced in. The stock last closed at US$100.27, with returns of 3.5% over the past week, 2.8% over the past month, 3.7% over the last year and 43.0% over three years. Year to date it is down 11.9% and up 21.6% over five years. Recent headlines have focused on Prudential Financial in the context of broader insurance sector sentiment and changing...

If you are wondering whether Walt Disney stock at around US$100 is offering value or just nostalgia, you are not alone. That is exactly what this breakdown will tackle. The share price last closed at US$100.48, with a 1% decline over the last 7 days, a 4% gain over 30 days, a 10.2% year to date decline, a 10.2% return over 1 year, a 0.7% return over 3 years and a 43.4% decline over 5 years. Recent headlines have focused on Disney's ongoing business reshaping, including its continued push...

Dentsply Sirona has reported Q1 2026 results showing essentially flat sales of US$880 million year on year but a swing from a US$20 million net profit to a US$10 million net loss, while also advancing its Return-to-Growth plan. At the same time, the company launched Smart View – Detect, the first FDA-cleared AI-enabled diagnostic aid for PARL detection in CBCT scans, and expanded its U.S. digital dentistry reach through an enhanced distribution agreement with Atlanta Dental Supply. We’ll now...

Why this quarter matters for Mercury Systems stock Mercury Systems (MRCY) has drawn fresh attention after third quarter results topped earnings and revenue expectations, accompanied by record bookings, record backlog, stronger adjusted EBITDA, and a smaller net loss than a year earlier. See our latest analysis for Mercury Systems. The latest quarterly beat has coincided with a clear upswing in momentum, with a 5.64% 1 day share price return and an 11.78% 30 day share price return, while 1...

FDA approves Jakafi XR extended-release tablets for myelofibrosis, polycythemia vera and graft-versus-host disease. Jakafi XR offers a once-daily dosing option that differs from existing formulations of ruxolitinib. The approval expands Incyte's Jakafi franchise and broadens its treatment toolkit across several serious blood and immune conditions. For investors watching NasdaqGS:INCY, this latest approval sits at the heart of the company’s core focus in hematology and oncology. Jakafi has...

Mattel has completed the acquisition of mobile game studio Mattel163, taking full control of its digital gaming business. The company is rolling out the new Mattel Brick Shop, a construction toy concept positioned to compete more directly with LEGO. Mattel is also deepening its entertainment efforts, tying its brands more closely to film and content projects. NasdaqGS:MAT is trading at $14.72, with the stock down 26.5% year to date and 30.3% over five years. In this context, the decision to...

In March 2026, MAC Cosmetics’ first-ever launch at Sephora, including Sephora at Kohl’s locations, quickly made it the number-five makeup brand there in its first month, with strong performance in lip products. An unusually high share of shoppers were entirely new to MAC and Sephora, highlighting how the partnership is expanding Kohl’s beauty reach and drawing incremental traffic. We’ll now explore how MAC’s strong customer acquisition at Sephora at Kohl’s may influence the company’s...

Excelerate Energy, Inc. recently declared a quarterly cash dividend of US$0.08 per share on its Class A common stock for the quarter ended March 31, 2026, payable on June 4, 2026 to stockholders of record as of May 20, 2026. This routine dividend affirmation comes just ahead of Excelerate Energy’s upcoming Q1 earnings release, putting income stability and operating performance under closer investor scrutiny. We’ll now examine how Excelerate’s latest dividend declaration, alongside the...

In recent weeks, LegalZoom.com drew fresh attention by offering free trademark legal support to Taylor Swift and other public figures to counter AI-driven impersonations, while investors also looked ahead to its upcoming earnings release. This high-profile move highlights how LegalZoom is positioning its brand at the center of emerging AI-related identity and intellectual property concerns. We’ll now examine how LegalZoom’s high-profile AI impersonation support offer could influence its...

In recent weeks, Critical Metals Corp. secured Greenland government approval to acquire a 70% stake in 60° North Greenland ApS and closed the transfer that lifted its ownership of the Tanbreez Mining Greenland rare earth project to 92.5%, while progressing plans to acquire the remaining 7.5% via European Lithium. These moves, alongside advancing pilot plant work at Tanbreez and building a Romanian mine-to-magnet JV focused on NATO and EU supply chains, materially deepen Critical Metals’...

MSA Safety (MSA) has just opened Q1 2026 earnings season with a run of solid headline figures, capped by Q4 2025 revenue of US$510.9 million and basic EPS of US$2.22. Over recent quarters the company has seen revenue move from US$499.7 million in Q4 2024 to US$421.3 million in Q1 2025 and then back to US$510.9 million in Q4 2025, while quarterly EPS ranged between roughly US$1.51 and US$2.23, setting up a results story where margins and profit quality are front and center for investors. See...

Wondering if Allison Transmission Holdings at around US$127 per share is still good value, or if most of the easy upside is already behind it. The stock has seen a 2% decline over the last 7 days, but is up 8.8% over 30 days, 28.7% year to date, 32.7% over 1 year and more than 7x over 5 years. This naturally raises questions about what is now priced in. Recent coverage has focused on Allison Transmission Holdings as a long term compounder for investors who held through the last several...

Agilent Technologies (A) is drawing fresh attention after the FDA approved its PD-L1 IHC 22C3 pharmDx test as the only companion diagnostic for certain esophageal and gastroesophageal junction cancers treated with pembrolizumab. See our latest analysis for Agilent Technologies. The FDA companion diagnostic approval arrives alongside a 4.77% 1 day share price return and a 2.32% 7 day share price return. However, the 90 day share price return of 11.62% and year to date share price return of...

Event overview and why it matters for Westamerica Bancorporation (WABC) Westamerica Bancorporation (WABC) has expanded its share repurchase authorization to 4,000,000 shares and lifted its quarterly dividend to $0.48, indicating a focus on returning cash to shareholders. See our latest analysis for Westamerica Bancorporation. At a share price of $54.75, Westamerica Bancorporation has a 30 day share price return of 5.63% and a year to date share price return of 14.47%, alongside a 3 year total...

If you have been wondering whether PG&E at US$16.33 is priced attractively or not, the key question is how that share price lines up against the company’s underlying value. The stock has been relatively steady over the last year with a 0.4% return year to date and a 3.3% decline over 12 months. Over the last 30 days it declined 8.1%, following a modest 0.4% gain over the past week. Recent news around PG&E has continued to focus on its role as a major California electric utility, including...

Selective Insurance Group (SIGI) has drawn fresh attention after first quarter 2026 results combined higher reported revenue with lower net income, along with affirmed common and preferred dividends and an update on its ongoing share repurchase activity. See our latest analysis for Selective Insurance Group. At a share price of US$82.15, SIGI has seen a 6.8% 1 month share price return but a 7.8% 3 month share price decline, while 1 year total shareholder return is a 6.0% loss. This suggests...

Carpenter Technology (CRS) raised its fiscal 2026 operating income guidance by at least 33% and paired that with third quarter results showing higher sales and net income. Together, these developments can quickly reshape how you think about this stock. See our latest analysis for Carpenter Technology. The raised guidance and stronger recent earnings have come alongside a 90 day share price return of 33.15% and a 1 year total shareholder return of 114.97%. This points to strong momentum that...

In late April 2026, The Hershey Company reported first-quarter sales of US$3,104.17 million and net income of US$435.11 million, declared quarterly dividends on its common and Class B shares, and reaffirmed its 2026 earnings guidance. A separate collaboration announced by Ryl Tea introduced zero-sugar Jolly Rancher-branded iced teas, highlighting how Hershey is extending its confectionery brands into new beverage formats. Now we’ll consider how Hershey’s reaffirmed full-year earnings...

In April 2026, Coursera reported first-quarter 2026 revenue of US$195.7 million, up from US$179.3 million a year earlier, while its net loss widened to US$20.5 million and loss per share increased to US$0.12. The company paired this with cautious commentary on its enterprise business, yet still projected second-quarter revenue of US$196 million to US$200 million and reaffirmed full-year 2026 revenue guidance of US$805 million to US$815 million, highlighting both growth and execution...

Arrowhead Pharmaceuticals announced that Australia’s Therapeutic Goods Administration has approved REDEMPLO (plozasiran), a first-in-class siRNA therapy self-administered quarterly, as an adjunct to diet for adults with familial chylomicronemia syndrome whose triglyceride levels remain uncontrolled on standard treatments. This decision makes REDEMPLO the first and only approved FCS therapy in Australia, extending Arrowhead’s rare lipid disorder footprint following prior authorizations in the...